Tadalafil 7 mg Capsule — Class II drug recall D-1440-2020
Terminated recall by MasterPharm LLC, reported 2020-08-05, distributed nationwide. Lack of Processing Controls (lack of assurance of conformity to specifications).
| Recall number | D-1440-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | MasterPharm LLC, South Richmond Hill, NY, United States |
| Recall initiated | 2020-07-02 |
| Classified | 2020-07-29 |
| Reported by FDA | 2020-08-05 |
| Terminated | 2024-02-23 |
| Distributed | Nationwide (US) |
| Quantity | 12,000 capsules |
| Expiration dates | 2020-07-06, 2020-07-20, 2020-08-11, 2020-08-22 |
Product
Tadalafil 7 mg Capsule, 90 capsules per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419, (866) 630-5600
Reason for recall
Lack of Processing Controls (lack of assurance of conformity to specifications).
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1440-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.